CVS Health Forecast, price target & analysts
CVS Health Target price 2025 - Analyst rating & recommendation
CVS Health Classifications & Recommendation:
CVS Health Price Target
| Target Price | $75.26 |
| Price | $67.29 |
| Potential |
11.85%
register free of charge
|
| Number of Estimates | 23 |
|
23 Analysts have issued a price target CVS Health 2026 .
The average CVS Health target price is $75.26.
This is
11.85%
register free of charge
$90.00
33.75%
register free of charge
$64.00
4.89%
register free of charge
|
|
| A rating was issued by 30 analysts: 19 Analysts recommend CVS Health to buy, 11 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CVS Health stock has an average upside potential 2026 of
11.85%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 372.69 | 389.19 |
| 4.02% | 4.43% | |
| EBITDA Margin | 3.90% | 4.07% |
| 30.04% | 4.48% | |
| Net Margin | 1.24% | 1.92% |
| 45.62% | 55.17% |
22 Analysts have issued a sales forecast CVS Health 2025 . The average CVS Health sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an CVS Health EBITDA forecast 2025. The average CVS Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 CVS Health Analysts have issued a net profit forecast 2025. The average CVS Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.66 | 5.94 |
| 43.43% | 62.30% | |
| P/E | 11.33 | |
| EV/Sales | 0.40 |
9 Analysts have issued a CVS Health forecast for earnings per share. The average CVS Health EPS is
This results in the following potential growth metrics and future valuations:
Current CVS Health Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Baird |
Locked
➜
Locked
|
Locked | Apr 15 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Feb 18 2025 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Baird:
Locked
➜
Locked
|
Apr 15 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Feb 18 2025 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Feb 13 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 13 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
